Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-Fluorouracil + Calcipotriol vs 5-Fluorouracil for Actinic Keratosis
2024-511409-42-00Phase 4Authorised
- Sponsor
- Maastricht University Medical Center+
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in actinic keratosis (AK) comparing 5-fluorouracil monotherapy with 5-fluorouracil + calcipotriol combination (2 arms). Planned start Sep 2024; status: authorised.
02
Drugs
fluorouracilcalcipotriol
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2024-511409-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511409-42-00.